BioAnalytics, Inc.

BioAnalytics has developed an immune complex which drastically increases sensitivity, specificity, and reduces cross reactivity in multiple immunology markets.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Champaign, IL, US
  • Currency USD
  • Founded October 2012
  • Employees 4
  • Website BioAnalyticSystems.com

Company Summary

BioAnalytics is an early-stage biotechnology company focused on designing the next generation of immunoassay technology. BioAnalytics concentrates on improving test speed, sensitivity, and fidelity in order to further academic research, pharmaceutical development, clinical laboratory sample analysis, and medical point-of-care diagnostics. The earliest applications of this technology will be in the ELISA kit and protein microarray markets.

Team

  • Lucas Smith
    CEO and Founder

    Luke is CEO and research director of BioAnalytics. He received his bachelors of science in biochemistry as well as his masters of science in biology from UIUC. In the past he has been involved in a number of research projects relating to the detection and spread of bacterial pathogens, and completed his master’s work studying gastric adenocarcinoma in the laboratory of Steven Blanke. Lucas is passionate about improving healthcare worldwide.

  • Michael Willard
    COO and Co-Founder

    Mike is a co-founder and COO of BioAnalytics. He attended the University of Illinois, where he pursued a degree in Political Science. After a few internships throughout state politics and multinational corporations, he realized that his future career should coincide with his entrepreneurial mindset. He has a proven track record of working in highly demanding industries while interacting with high profile clients.

Advisors

  • Teddy Scott, Polsinelli PC
    Lawyer
    Unconfirmed

Previous Investors

  • Dr. David Smith
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free